The MIF SNP rs755622 is a germline determinant of tumor immune activation in Glioblastoma
Alban, T.; Grabowski, M. M.; Otvos, B.; Watson, D. B.; Zalavadia, A.; Makarav, V.; Troike, K. M.; McGraw, M.; Rabljenovic, A.; Lauko, A.; Neumann, C. K. A.; Roversi, G.; Waite, K.; Cioffi, G.; Patil, N.; Tran, T.; McCortney, K.; Steffens, A.; Diaz, M.; Brown, J. M.; Egan, K.; Horbinski, C.; Barnholtz-sloan, J.; Vogelbaum, M.; Bucala, R.; Chan, T.; Ahluwalia, M.; Lathia, J.
Show abstract
While immunotherapies have shown durable responses for multiple tumors, their efficacy remains limited in some advanced cancers, including glioblastoma. This may be due to differences in the immune landscape, as the glioblastoma microenvironment strongly favors immunosuppressive myeloid cells, which are linked to an elevation in immune-suppressive cytokines, including macrophage migration inhibitory factor (MIF). We now find that a single-nucleotide polymorphism (SNP) rs755622 in the MIF promoter associates with increased leukocyte infiltration in glioblastoma. Furthermore, we identified lactotransferrin expression as being associated with the rs755622 SNP, which could also be used as a biomarker for immune infiltrated tumors. These findings provide the first example in glioblastoma of a germline SNP that underlies differences in the immune microenvironment and identifies high lactotransferrin as a potential factor promoting immune activation.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Preclinical modeling of surgery and steroid therapy for glioblastoma reveals changes in immunophenotype that are associated with tumor growth and outcome 96%
- CD8+ T-cell-mediated immunoediting influences genomic evolution and immune evasion in murine gliomas 95%
- Myeloid cell-associated resistance to PD-1/PD-L1 blockade in urothelial cancer revealed through bulk and single-cell RNA sequencing 94%
Similar papers in this journal
- GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma 95%
- Differential Phagocytosis induces Diverse Macrophage Activation States in Malignant Gliomas 94%
- Reversible Downregulation of HLA Class I in Adenoid Cystic Carcinoma 94%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Tumor cell-derived spermidine promotes a pro-tumorigenic immune microenvironment in glioblastoma via CD8+ T cell inhibition 96%
- SLIT2-ROBO signaling in tumor-associated microglia/macrophages drives glioblastoma immunosuppression and vascular dysmorphia 96%
- IL-7-mediated expansion of autologous lymphocytes increases CD8+ VLA-4 expression and accumulation in glioblastoma models 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.